BEAT (Heartbeam, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by BEAT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-24 | Branislav Vajdic | President | A | — | — |
| 2026-07-24 | Kenneth Harry Persen | Chief Technology Officer | A | — | — |
| 2026-07-24 | Tim Cruickshank | CFO | A | — | — |
| 2013-07-30 | REBECCA W RIMEL | Director | A | — | — |
| 2013-07-30 | KIRK E GORMAN | Director | A | — | — |
| 2013-07-30 | Anthony James Conti | Director | A | — | — |
| 2013-07-30 | RONALD A AHRENS | Director | A | — | — |
| 2013-07-30 | ROBERT J. RUBIN | Director | A | — | — |
| 2013-07-30 | ERIC N PRYSTOWSKY | Director | A | — | — |
| 2013-02-21 | Daniel Wisniewski | SVP - Business Operations | A | — | — |
| 2013-02-21 | Fred Broadway | Senior Vice President | A | — | — |
| 2013-02-21 | RONALD A AHRENS | Director | Buy | — | — |
| 2013-02-21 | Heather C Getz | Chief Financial Officer | A | — | — |
| 2013-02-21 | George Hrenko | Senior Vice President | A | — | — |
| 2013-02-21 | Anna McNamara | Senior Vice Pres/Clinical Op. | A | — | — |
| 2013-02-21 | Joseph H Capper | President and CEO | A | — | — |
| 2013-02-21 | Michael Geldart | Senior Vice President | A | — | — |
| 2013-02-21 | Peter Ferola | Senior Vice President | A | — | — |
| 2012-11-20 | RONALD A AHRENS | Director | Buy | — | — |
| 2012-11-13 | RONALD A AHRENS | Director | Buy | — | — |
| 2012-09-06 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-09-04 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-31 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-29 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-28 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-27 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-24 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-22 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-21 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-08-20 | Joseph H Capper | President and CEO | Buy | — | — |
| 2012-06-13 | Michael Geldart | SVP-Corp Strategy & Bus Dev. | A | — | — |
| 2012-05-09 | ERIC N PRYSTOWSKY | Director | A | — | — |
| 2012-05-09 | Anthony James Conti | Director | A | — | — |
| 2012-05-09 | KIRK E GORMAN | Director | A | — | — |
| 2012-05-09 | RONALD A AHRENS | Director | A | — | — |
| 2012-05-09 | REBECCA W RIMEL | Director | A | — | — |
| 2012-05-09 | ROBERT J. RUBIN | Director | A | — | — |
| 2012-02-23 | George Hrenko | Senior Vice President | A | — | — |
| 2012-02-23 | Peter Ferola | Senior Vice President | A | — | — |
| 2012-02-23 | Jareer Kasrawi | Senior Vice President | A | — | — |
| 2012-02-23 | Anthony Schuler | Senior Vice President | A | — | — |
| 2012-02-23 | Anna McNamara | Senior Vice Pres/Clinical Op. | A | — | — |
| 2012-02-23 | Joseph H Capper | President and CEO | A | — | — |
| 2012-02-23 | Heather C Getz | Chief Financial Officer | A | — | — |
| 2012-02-23 | Charles Gropper | Senior Vice President | A | — | — |
| 2012-02-23 | Daniel Wisniewski | SVP - Business Operations | A | — | — |
| 2011-05-04 | Jareer Kasrawi | Senior Vice President | A | — | — |
| 2011-05-04 | Anthony Schuler | Senior Vice President | A | — | — |
| 2011-05-03 | REBECCA W RIMEL | Director | A | — | — |
| 2011-05-03 | ERIC N PRYSTOWSKY | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President | 3,709,914 | — |
| — | Chief Technology Officer | 448,290 | — |
| — | CFO | 239,990 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BEAT quote page; the site-wide leaderboard is on the insider transactions hub.